Thus, the role of the AC/cAMP pathway as a co‐mediator, with the PLC/IP3 pathway, of the hepatic glucose‐mobilizing and hyperglycemic actions of glucagon in T1D remains unclear. The gene discussed is HSPG2; the disease is type 1 diabetes mellitus.